Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Propranolol LA is a generic equivalent of Inderal LA
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Subscribe To Our Newsletter & Stay Updated